Literature DB >> 3886804

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

M A Karmali, M Petric, C Lim, P C Fleming, G S Arbus, H Lior.   

Abstract

Forty pediatric patients with idiopathic hemolytic uremic syndrome (HUS) were investigated for evidence of infection by Verotoxin-producing Escherichia coli (VTEC). Fecal VTEC (belonging to at least six different O serogroups including O26, O111, O113, O121, O145, and O157) or specifically neutralizable free-fecal Verotoxin (VT) or both were detected in 24 (60%) patients but were not detected in 40 matched controls. Ten of 15 of the former developed fourfold or greater rises in VT-neutralizing antibody titers, as did six other patients who were negative for both fecal VTEC and VT. A total of 30 (75%) patients had evidence of VTEC infection by one or more criteria. We concluded that a significant association exists between idiopathic HUS and infection by VTEC. The detection of free-fecal VT was the most important procedure for the early diagnosis of this infection because, in our study, VTEC were never isolated in the absence of fecal VT, whereas fecal VT was often present even when VTEC were undetectable.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886804     DOI: 10.1093/infdis/151.5.775

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  472 in total

1.  Effects of Shiga toxin 2 on lethality, fetuses, delivery, and puerperal behavior in pregnant mice.

Authors:  K Yoshimura; J Fujii; A Tanimoto; T Yutsudo; M Kashimura; S Yoshida
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Effect of Shiga toxin 2 on water and ion transport in human colon in vitro.

Authors:  P Fiorito; J M Burgos; M F Miyakawa; M Rivas; G Chillemi; D Berkowski; E Zotta; C Silberstein; C Ibarra
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

3.  Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide.

Authors:  T Waddell; A Cohen; C A Lingwood
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

4.  Outbreak of Escherichia coli O157:H7 infection in a large family.

Authors:  K Ludwig; H Ruder; M Bitzan; S Zimmermann; H Karch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-03       Impact factor: 3.267

5.  Identification and characterization of a new variant of Shiga toxin 1 in Escherichia coli ONT:H19 of bovine origin.

Authors:  Christine Bürk; Richard Dietrich; Gabriele Açar; Maximilian Moravek; Michael Bülte; Erwin Märtlbauer
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

6.  Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1.

Authors:  Satoshi Ishikawa; Kazuyoshi Kawahara; Yutaka Kagami; Yasunori Isshiki; Aki Kaneko; Hidenori Matsui; Nobuhiko Okada; Hirofumi Danbara
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  An epidemiological study on Verotoxin-producing Escherichia coli (VTEC) infection among population of northern region of Iran (Mazandaran and Golestan provinces).

Authors:  Mohammad Mehdi Aslani; Saeid Bouzari
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

8.  Use of clustered regularly interspaced short palindromic repeat sequence polymorphisms for specific detection of enterohemorrhagic Escherichia coli strains of serotypes O26:H11, O45:H2, O103:H2, O111:H8, O121:H19, O145:H28, and O157:H7 by real-time PCR.

Authors:  Sabine Delannoy; Lothar Beutin; Patrick Fach
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

9.  Risk factors for poor renal prognosis in children with hemolytic uremic syndrome.

Authors:  Alessandra Gianviti; Alberto E Tozzi; Laura De Petris; Alfredo Caprioli; Lucilla Ravà; Alberto Edefonti; Gianluigi Ardissino; Giovanni Montini; Graziella Zacchello; Alfonso Ferretti; Carmine Pecoraro; Tommaso De Palo; Angela Caringella; Maurizio Gaido; Rosanna Coppo; Francesco Perfumo; Nunzia Miglietti; Ilse Ratsche; Rosa Penza; Giovambattista Capasso; Silvio Maringhini; Salvatore Li Volti; Carmen Setzu; Marco Pennesi; Alberto Bettinelli; Leopoldo Peratoner; Ivana Pela; Elio Salvaggio; Giuliana Lama; Salvatore Maffei; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2003-10-31       Impact factor: 3.714

10.  Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.

Authors:  J Fujii; T Kita; S Yoshida; T Takeda; H Kobayashi; N Tanaka; K Ohsato; Y Mizuguchi
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.